Skip to main content
Top
Published in: HSS Journal ® 2/2013

01-07-2013 | Case Report

First Time Myocardial Infarction in a Rheumatic Patient After Elective Arthroplasty

Authors: James J. Calloway, MD, Susan M. Goodman, MD, Wesley Hollomon, MD, Linda A. Russell, MD, Daniel Krauser, MD

Published in: HSS Journal ® | Issue 2/2013

Login to get access

Abstract

The management of perioperative cardiovascular risk in patients with rheumatoid arthritis (RA) is challenging due to the independent contribution to risk by high grade inflammatory mechanisms and the underestimation of risk by traditional cardiac risk factors alone. RA is associated with accelerated rates of subclinical atherosclerosis and markedly higher rates of both myocardial infarction and sudden cardiac death over non-RA controls. There is an absence of prospectively validated perioperative coronary heart disease (CHD) risk assessment tools for this unique patient population and available guidelines may fail to identify those patients most at risk. We examine a singular case of first time myocardial infarction after uncomplicated elective surgery in an adult RA patient with an unrevealing preoperative cardiac assessment. We also review the current literature for shared pathogenic mechanisms between systemic inflammation and atherosclerosis, discuss clinical and biologic markers such as C-reactive protein (CRP) in RA patients associated with heightened cardiac risk and discuss recommendations based on available evidence for cardiovascular risk management in this at risk cohort.
Appendix
Available only for authorised users
Literature
1.
go back to reference Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol. 2012;8:32–41.CrossRef Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol. 2012;8:32–41.CrossRef
2.
go back to reference Aubry MC, Mardit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007;34:937–42.PubMed Aubry MC, Mardit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007;34:937–42.PubMed
3.
go back to reference Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–1697.PubMedCrossRef Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–1697.PubMedCrossRef
4.
go back to reference Devereaux PJ, Yang H, Yusuf S, et al. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371(9627):1839.PubMedCrossRef Devereaux PJ, Yang H, Yusuf S, et al. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371(9627):1839.PubMedCrossRef
5.
go back to reference Fayad Z, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506–510.PubMedCrossRef Fayad Z, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506–510.PubMedCrossRef
6.
go back to reference Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36(6):729.PubMedCrossRef Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36(6):729.PubMedCrossRef
7.
go back to reference Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first time acute myocardial infarction. Am J Cardiol. 2004;93:198–200.PubMedCrossRef Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first time acute myocardial infarction. Am J Cardiol. 2004;93:198–200.PubMedCrossRef
8.
go back to reference Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J AM Coll Cardiol. 2009;54(22):e19–e44.CrossRef Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J AM Coll Cardiol. 2009;54(22):e19–e44.CrossRef
9.
go back to reference Galvin EM, O’Donnell D, Leonard IE. Rheumatoid arthritis: A significant but often underestimated risk factor for perioperative cardiac morbidity. Anesthesiology. 2005;103:910–11.PubMedCrossRef Galvin EM, O’Donnell D, Leonard IE. Rheumatoid arthritis: A significant but often underestimated risk factor for perioperative cardiac morbidity. Anesthesiology. 2005;103:910–11.PubMedCrossRef
10.
go back to reference Greenberg JD, Kremer JM, Curtis JR, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:576–582.PubMedCrossRef Greenberg JD, Kremer JM, Curtis JR, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:576–582.PubMedCrossRef
11.
go back to reference Houten JK, Tandon A. Comparison of postoperative values for c-reactive protein in minimally invasive and open lumbar spinal fusion surgery. Surg Neurol Int. 2011;2:94.PubMedCrossRef Houten JK, Tandon A. Comparison of postoperative values for c-reactive protein in minimally invasive and open lumbar spinal fusion surgery. Surg Neurol Int. 2011;2:94.PubMedCrossRef
12.
go back to reference Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased Unrecognized Coronary Heart Disease and Sudden Deaths in Rheumatoid Arthritis. Arthritis Rheum. 2005;52:402–411.PubMedCrossRef Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased Unrecognized Coronary Heart Disease and Sudden Deaths in Rheumatoid Arthritis. Arthritis Rheum. 2005;52:402–411.PubMedCrossRef
13.
go back to reference McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo controlled trial. Lancet. 2004;363(9426):2015–2021.PubMedCrossRef McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo controlled trial. Lancet. 2004;363(9426):2015–2021.PubMedCrossRef
14.
go back to reference McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219.PubMedCrossRef McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219.PubMedCrossRef
15.
go back to reference Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54(1):49.PubMedCrossRef Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54(1):49.PubMedCrossRef
16.
go back to reference Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the Quest-RA study. Arthritis Res Ther. 2008;10(2):105.CrossRef Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the Quest-RA study. Arthritis Res Ther. 2008;10(2):105.CrossRef
17.
go back to reference Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305–12.PubMedCrossRef Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305–12.PubMedCrossRef
18.
go back to reference Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence- based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;68:325–331.CrossRef Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence- based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;68:325–331.CrossRef
19.
go back to reference Provan SA, Semb AG, Hisdal J, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross sectional comparative study. Ann Rheum Dis. 2011;70:812–817.PubMedCrossRef Provan SA, Semb AG, Hisdal J, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross sectional comparative study. Ann Rheum Dis. 2011;70:812–817.PubMedCrossRef
20.
go back to reference Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359:2195–2207.PubMedCrossRef Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359:2195–2207.PubMedCrossRef
21.
go back to reference Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249–256.PubMedCrossRef Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249–256.PubMedCrossRef
23.
go back to reference Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–1307.PubMedCrossRef Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–1307.PubMedCrossRef
24.
go back to reference Solomon DH, Kremer JM, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69:1920–1925.PubMedCrossRef Solomon DH, Kremer JM, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69:1920–1925.PubMedCrossRef
25.
go back to reference Urban MK, Jules-Elysee K, Loughlin C, Kelsey W, Flynn E. The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J. 2008;4:76–80.PubMedCrossRef Urban MK, Jules-Elysee K, Loughlin C, Kelsey W, Flynn E. The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J. 2008;4:76–80.PubMedCrossRef
26.
go back to reference van Halm VP, Peters MJL, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross sectional study, the CARRÉ Investigation. Ann Rheum Dis. 2009;68:1395–1400.PubMedCrossRef van Halm VP, Peters MJL, Voskuyl AE, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross sectional study, the CARRÉ Investigation. Ann Rheum Dis. 2009;68:1395–1400.PubMedCrossRef
27.
go back to reference Urban MK, Jules-Elysee KM, Beckman JB, et al. Pulmonary injury in patients undergoing complex spine surgery. The Spine Journal. 2005;5:269–276.PubMedCrossRef Urban MK, Jules-Elysee KM, Beckman JB, et al. Pulmonary injury in patients undergoing complex spine surgery. The Spine Journal. 2005;5:269–276.PubMedCrossRef
28.
go back to reference US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6):396.CrossRef US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6):396.CrossRef
Metadata
Title
First Time Myocardial Infarction in a Rheumatic Patient After Elective Arthroplasty
Authors
James J. Calloway, MD
Susan M. Goodman, MD
Wesley Hollomon, MD
Linda A. Russell, MD
Daniel Krauser, MD
Publication date
01-07-2013
Publisher
Springer US
Published in
HSS Journal ® / Issue 2/2013
Print ISSN: 1556-3316
Electronic ISSN: 1556-3324
DOI
https://doi.org/10.1007/s11420-012-9309-5

Other articles of this Issue 2/2013

HSS Journal ® 2/2013 Go to the issue